Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Chisaki Yugo

Kyoto Pharmaceutical University

Japan

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

30%

Immunology

30%

Immunotherapy

30%

Oncology

30%

Graft-versus-host Disease

20%

Clinical Risk

20%

Drug Safety

10%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles4

A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors

Article Link

Year:

2022

The Occurrence of Encephalitis Due to Immune Checkpoint Inhibitors: A Pharmacovigilance Study

Article Link

Year:

2022

Cost-effectiveness Analysis of Atezolizumab Plus Nab-Paclitaxel for Advanced PD-L1 Positive Triple-Negative Breast Cancer in Japan

Article Link

Year:

2021

Factors Associated With Efficacy and Nivolumab-Related Interstitial Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Survey.

Article Link

Year:

2020

Collaborators1

Yoshitaka Yano

Kyoto Pharmaceutical University

JAPAN

How do I reach out?

Meet Kite AI